Data protection Impressum

Newsroom

Microsoft deepens its commitment to Switzerland with a strategic investment spanning infrastructure, education, and responsible AI, also placing Geneva at the center of global collaboration.

Microsoft invests USD 400 million to boost Switzerland’s AI future

3 June 2025

Faced with invisible but worrying pollution, French start-up Biostart is developing innovative water purification technology and has chosen Western Switzerland to accelerate its R&D.

Biostart sets up shop at EPFL Innovation Park to combat micropollutants in water

3 June 2025

With the Swiss Federal Council launching a consultation on a new law for space operations, the importance of Switzerland’s aerospace sector is more evident than ever. Western Switzerland, home to pioneering companies, world-class research institutions, and cutting-edge space technology, is playing a crucial role in shaping the future of space exploration and satellite innovation.

Western Switzerland, a rising hub for aerospace innovation

Top Stories Western Switzerland

Top Stories from Western Switzerland (May 2025)

28 May 2025

In the heart of Fribourg, the Adolphe Merkle Institute (AMI) has grown into a globally recognized center of excellence in materials science. Founded in 2008 through the visionary endowment of Swiss entrepreneur Dr. Adolphe Merkle, the institute was built on a simple yet powerful belief: fundamental science can bridge the gap to real-world impact.

Adolphe Merkle Institute: Where science meets application in the heart of Fribourg

Western Switzerland is rapidly becoming a hotspot for biomanufacturing and life sciences companies, thanks to its strong infrastructure, skilled talent, and business-friendly policies. Yassin Nahi, GGBa (Greater Geneva Bern area) Life Science Director, shares how the region's research hubs, academic institutions, and regulatory support make it an ideal location for companies in this sector.

Why Switzerland

Why Western Switzerland for Biomanufacturing and Life Sciences Companies: an interview with expert Yassin Nahi

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

With a CHF 13 million investment, Mestel has opened a cutting-edge facility in Rossens to boost production of high-end rubber watch straps and smart wearable components for the luxury industry.

Mestel inaugurates CHF 13 million high-tech facility in the canton of Fribourg

26 May 2025

Bern-based medtech LEM Surgical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Dynamis Robotic Surgical System. The announcement marks a major regulatory milestone for the company and paves the way for the introduction of its next-generation spine surgery robot into U.S. hospitals.

LEM Surgical receives FDA clearance for its Dynamis Robotic Surgical System

26 May 2025

1 2 3 4 5 6 … 141